Turing Pharmaceuticals CEO Martin Shkreli on Friday defended, without apology, his decision to up the price of the drug Daraprim from $3.50 a pill to $750, during an online interview Friday at ...

Turing Pharmaceuticals will slash the price hospitals pay for Daraprim by 50 percent following backlash over owner Martin Shkreli's decision to hike the price of the AIDS drug by 5,000 percent, the ...

Lawmakers at the House Oversight Committee hearing hoped to scold Shkreli and other drug-company executives for excessively raising the prices of life-saving drugs. But instead of giving his ...

There were no generic alternatives to a lifesaving drug when Shkreli jacked up its price by more than $700 per pill in 2015. Reading time 2 minutes Martin Shkreli has been fighting a $64.6 million ...

Is Martin Shkreli the picture of a new breed of pharmaceutical entrepreneur? Or is he the poster boy for all that's wrong in the health care industry? Is Martin Shkreli the picture of a new breed of ...

Martin Shkreli, the 32-year-old pharmaceutical CEO who drew widespread outrage by remorselessly raising the price of a life-saving pill by 4,000 percent, has been arrested on charges of security fraud ...

The former pharmaceutical executive sought to appeal a $64.6 million judgement issued against him for inflating drug cost and trying to stifle generics from launching. The U.S. Supreme Court on Monday ...

On January 23, the U.S. Court of Appeals for the Second Circuit affirmed a district court ruling that Martin Shkreli, CEO of Vyera Pharmaceuticals (Vyera), violated federal and state laws by engaging ...

People have written a lot about Martin Shkreli. Now he’ll reflect on the week during a panel with some of biopharma’s best journalists at 4 pm Eastern today – and it will be broadcast live online.